Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification
Open Access
- 11 March 2010
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 115 (10) , 1985-1992
Abstract
Acute erythroid leukemia (AEL) is a rare type of acute myeloid leukemia (AML) for which diagnostic criteria have been refined in the 2008 World Health Organization (WHO) classification of AML. The relationship of AEL to myelodysplastic syndromes (MDSs) and to AML with myelodysplasia-related changes (AML-MRC) is not clearly defined. We conducted a retrospective, multi-institutional study of patients with AEL and compared them with patients with MDS or AML-MRC with erythroid hyperplasia (≥ 50% erythroid cells). Among a total of 124 patients with AEL, 32% had a history of MDS or chronic cytopenia, 32% had therapy-related disease, and 35% had de novo disease. Sixty-four percent of patients had unfavorable AML risk-group karyotypes. FLT3 and RAS mutations were infrequent, occurring in 6% and 2%, respectively. The median overall survival (OS) of all AEL patients was 8 months, comparable with that of patients with MDS or AML-MRC with erythroid hyperplasia. The OS was related to cytogenetic risk group, but not blast count or morphologic dysplasia. Our findings suggest that AEL is in the continuum of MDS and AML with erythroid hyperplasia, where karyotype rather than an arbitrary blast cutoff represents the most important prognostic factor.Keywords
This publication has 23 references indexed in Scilit:
- Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionLeukemia, 2009
- Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratificationLaboratory Investigation, 2008
- New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsBlood, 2007
- Therapy-Related Myelodysplastic SyndromeAmerican Journal of Clinical Pathology, 2007
- Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposalsBritish Journal of Haematology, 2005
- Cytogenetic study of 75 erythroleukemiasCancer Genetics and Cytogenetics, 2005
- Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemiasLeukemia, 2005
- Diagnostic criteria for acute erythroleukemiaBlood, 2003
- Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)Blood, 2002
- Erythroleukemia: a need for a new definitionLeukemia, 2002